1 year return (CAGR)
118.94%
Acumen Pharmaceuticals Inc Exchange (NASDAQ, USD)
ABOS
2.89
+0.10 (+3.58%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-19.86%
5 year return (CAGR)
-30.87%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
209.00M
Price/Sales
-
Ent value
208.30M
Price/Book
3.65
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
50.94%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.77 |
| Daily high | 2.90 |
| Daily low | 2.69 |
| Daily Volume | 359K |
| All-time high | 20.28 |
| 1y analyst estimate | 7.40 |
| Beta | 0.33 |
| EPS (TTM) | -1.45 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 30 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ABOS | S&P500 | |
| Current price drop from All-time high | -85.75% | -2.63% |
| Highest price drop | -95.56% | -56.47% |
| Date of highest drop | 17 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -77.74% | -10.68% |
| Avg time to new high | 654 days | 12 days |
| Max time to new high | 1306 days | 1805 days |
News
